U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07760896) titled 'The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness' on Aug. 07.
Brief Summary: The goal of this clinical trial is to learn whether a 30-day structured wellness program may support physical and emotional well-being in adults who are already taking a GLP-1 or dual GIP/GLP-1 medication for an FDA-approved indication. The study does not evaluate the GLP-1 medication itself or make changes to participants' medication treatment.
The main questions it aims to answer are:
1. Are there changes in participants' physical and emotional well-being after completing the 30-day wellness program?
2. Are there changes in areas such as mood, ...